- Target
- CD45RA
- Reactivity
- Human
- Applications
- WB
- MW(Calculated)
- 147kD
- MW(Observed)
- 147kD
- Host Species
- Rabbit
- Isotype
- IgG
- Conjugate/Modification
- Unmodified
- Recommended Dilution Ratio
- WB 1:2000-1:10000
- Formulation
- PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
- Purification
- The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.
- Storage
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Concentration
- 1 mg/ml
- Clonality
- Polyclonal
- Immunogen
- --
- Specificity
- Endogenous
- Gene Name
- PTPRC
- Protein Name
- Receptor-type tyrosine-protein phosphatase C
- Other Name
- PTPRC; / CD45; / Receptor-type tyrosine-protein phosphatase C; / Leukocyte common antigen; / L-CA; / T200; / CD antigen CD45
- Species
- Human
- Gene ID
- 5788
- Uniprot
- P08575-8,
- Species
- Mouse
- Gene ID
- --
- Uniprot
- P06800,
- Species
- Rat
- Gene ID
- 24699
- Uniprot
- P04157
- Cellular Localization
- Cell membrane; Single-pass type I membrane protein . Membrane raft . Colocalized with DPP4 in membrane rafts. .
- Tissue Expression
- Isoform 1: Detected in thymocytes. Isoform 2: Detected in thymocytes. Isoform 3: Detected in thymocytes. Isoform 4: Not detected in thymocytes. Isoform 5: Detected in thymocytes. Isoform 6: Not detected in thymocytes. Isoform 7: Detected in thymocytes. Isoform 8: Not detected in thymocytes.
- Signaling_pathway
- Organismal Systems >> Immune system >> T cell receptor signaling pathway;Organismal Systems >> Immune system >> Fc gamma R-mediated phagocytosis;Human Diseases >> Immune disease >> Primary immunodeficiency;Environmental Information Processing >> Signaling molecules and interaction >> Cell adhesion molecules
- Research Areas
- >>Cell adhesion molecules; / >>T cell receptor signaling pathway; / >>Fc gamma R-mediated phagocytosis; / >>Salmonella infection; / >>Primary immunodeficiency
- Function
- Alternative products:At least 8 isoforms are produced,Catalytic activity:Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate.,Disease:Defects in PTPRC are a cause of severe combined immunodeficiency autosomal recessive T-cell-negative/B-cell-positive/NK-cell-positive (T(-)B(+)NK(+)SCID) [MIM:608971]. SCID refers to a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients with SCID present in infancy with recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development.,Disease:Genetic variations in PTPRC are involved in multiple sclerosis susceptibility (MS) [MIM:126200]. MS is a neurodegenerative disorder characterized by the gradual accumulation of focal plaques of demyelination particularly in the periventricular areas of the brain. Peripheral nerves are not affected. Onset usually in third or fourth decade with intermittent progression over an extended period. The cause is still uncertain.,Domain:The first PTPase domain interacts with SKAP1.,Function:Required for T-cell activation through the antigen receptor. The first PTPase domain has enzymatic activity, while the second one seems to affect the substrate specificity of the first one. Upon T-cell activation, recruits an dephosphorylates SKAP1 and FYN.,online information:CD45 entry,online information:PTPRC mutation db,PTM:Heavily N- and O-glycosylated.,similarity:Belongs to the protein-tyrosine phosphatase family. Receptor class 1/6 subfamily.,similarity:Contains 2 fibronectin type-III domains.,similarity:Contains 2 tyrosine-protein phosphatase domains.,subunit:Binds GANAB and PRKCSH (By similarity). Interacts with SKAP1.,